Sage Journals: Discover world-class research

Retricted access

Research article

First published 2013-1

Relationship Between Progression-Free Survival and Overall Survival Benefit

Lijun Zhang, Chia-Wen Ko, Shenghui Tang [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2014-2

Modelling of overall survival by an association between progression-free and post-progression survival using a conditional distribution

Mohamed C Belkacemi, Christel Castelli, Mohamed R Remita [...]

Statistical Modelling

Open access

Research article

First published 2024-04-25

The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer

Fitran Amansyah, Prihantono Prihantono, Firdaus Hamid [...]

Breast Disease

Open access

Research article

First published 2017

Roles of kallikrein-2 biomarkers (free-hK2 and pro-hK2) for predicting prostate cancer progression-free survival

Anatilde Gonzalez Guerrico, David Hillman, Jeffery Karnes [...]

Journal of Circulating Biomarkers

Open access

Research article

First published 2022

Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis

Weiming Han, Lan Wang, Chen Li [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2013-8

Correlation between Cerebral Blood Volume Measurements by Perfusion-Weighted Magnetic Resonance Imaging and Two-Year Progression-Free Survival in Gliomas

M.V. Spampinato, C. Schiarelli, A. Cianfoni [...]

The Neuroradiology Journal

Open access

Research article

First published 2025

Long-Term Intracranial Progression-Free Survival in Lung Cancer Brain Metastases Extended Beyond 50 Months with Gubenxiaoyi Formula (GBXY): A Groundbreaking Case Study

Zhengzheng Yang, Haiming Li, Lei Chen [...]

Integrative Cancer Therapies

Open access

Review article

First published 2017-11

Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive,HER2-negative advanced breast cancer: review

Tomás Reinert, Carlos H. Barrios

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2021-6

68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case report

Ozgur Tanriverdi, Mehmet L Tarimer, Ceren D Pak [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2021-12

Long progression-free survival with cabozantinib in a heavily pretreated patient with metastatic renal cell carcinoma: a case report

Cecilia Nasso, Roberto Sabbatini, Cinzia Baldessari [...]

Tumori Journal

Search results